Phathom Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $201.4M | $-253.6M | $297.3M |
| FY2025 | $209.1M | $-438.2M | $130.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $201.4M | $-253.6M | $297.3M |
| FY2025 | $209.1M | $-438.2M | $130.0M |